Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia

by Eric Achtyes, Adam Simmons, Anna Skabeev, Nikki Levy, Ying Jiang, Patricia Marcy, Peter J. Weiden
Published 2018-09-01

Long-term effect of aripiprazole lauroxil on health-related quality of life in patients with schizophrenia

by Joseph P. McEvoy, Peter J. Weiden, Paul H. Lysaker, Xiaowu Sun, Amy K. O’Sullivan
Published 2021-03-01

Impaired insight in schizophrenia: impact on patient-reported and physician-reported outcome measures in a randomized controlled trial

by Paul H. Lysaker, Peter J. Weiden, Xiaowu Sun, Amy K. O’Sullivan, Joseph P. McEvoy
Published 2022-08-01

Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outco...

by Henry A. Nasrallah, Peter J. Weiden, David P. Walling, Yangchun Du, Baiyun Yao, Sergey Yagoda, Amy Claxton
Published 2021-10-01

Antipsychotic treatment experiences of people with bipolar I disorder: patient perspectives from an online survey

by Leona Bessonova, Dawn I. Velligan, Peter J. Weiden, Amy K. O’Sullivan, Aaron Yarlas, Martha Bayliss, Nishtha Baranwal, Kaitlin Rychlec, Julia Carpenter-Conlin, Michael J. Doane, Martha Sajatovic
Published 2020-07-01